0001410428 false 0001410428 2022-10-04
2022-10-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC
20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(D) of the Securities Exchange Act
Of 1934
Date of report (Date of earliest event reported):
October 4, 2022
XpresSpa Group, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-34785 |
|
20-4988129 |
(Commission File Number) |
|
(IRS
Employer Identification No.) |
254 West 31st
Street,
11th Floor,
New York,
New York |
|
10001 |
(Address of Principal Executive
Offices) |
|
(Zip
Code) |
(212)
309-7549
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
¨ |
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
¨ |
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
¨ |
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
¨ |
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
Title of each
class |
|
Trading Symbol(s) |
|
Name of each exchange on which
registered |
Common Stock, par value $0.01 per share |
|
XSPA |
|
The Nasdaq Stock Market |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ¨
|
Item 4.01 |
Changes in Registrant’s
Certifying Accountant. |
(a) Dismissal of
Previous Independent Registered Accounting Firm
Based on information provided to XpresSpa Group, Inc. (the
“Company”) by its independent registered public accounting firm,
Friedman LLP (“Friedman”), effective September 1, 2022 Friedman
combined with Marcum LLP (“Marcum”) and continued to operate as an
independent registered public accounting firm. On October 4, 2022,
after the conclusion of the Company’s Annual Meeting of
Stockholders described under Item 5.07 below, the Audit Committee
(the “Audit Committee”) of the Board of Directors of the Company
approved the dismissal of Friedman and the engagement of Marcum to
serve as the Company’s independent registered public accounting
firm. The services previously provided by Friedman will now be
provided by Marcum.
Friedman’s report on the Company’s consolidated financial
statements as of December 31, 2021 and December 31, 2020, did not
contain an adverse opinion or a disclaimer of opinion, nor was it
qualified or modified as to uncertainty, audit scope or accounting
principles.
During the years ended December 31, 2021 and December 31, 2020 and
the subsequent interim period through October 4, 2022, there were
no “disagreements” (as such term is defined in Item 304(a)(1)(iv)
of Regulation S-K and the related instructions to Item 304) with
Friedman on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure,
which disagreements if not resolved to the satisfaction of
Friedman, would have caused Friedman to make reference to the
subject matter of the disagreements or reportable events in
connection with its reports on the financial statements for such
years. During the years ended December 31, 2021 and 2020 and the
subsequent interim period through October 4, 2022, there have been
no “reportable events” (as such term is defined in Item
304(a)(1)(v) of Regulation S-K), except for the material weakness
identified in the Company’s internal control over its financial
close and reporting process.
The Company provided Friedman with a copy of the disclosure it is
making herein in response to Item 304(a) of Regulation S-K and
requested that Friedman furnish the Company with a copy of its
letter addressed to the Securities and Exchange Commission (the
“SEC”), pursuant to Item 304(a)(3) of Regulation S-K, stating
whether Friedman agrees with the statements made by the Company in
response to Item 304(a) of Regulation S-K. A copy of Friedman’s
letter to the SEC dated October 7, 2022 is filed as Exhibit 16.1 to
this Current Report on Form 8-K.
(b) Appointment of New
Independent Registered Public Accounting Firm
As noted above, on October 4, 2022, the Audit Committee approved
the dismissal of Friedman and the engagement of Marcum to serve as
the Company’s independent registered public accounting firm. The
services previously provided by Friedman will now be provided by
Marcum.
During the fiscal years ended December 31, 2021 and December 31,
2020 and through the subsequent interim period as of October 4,
2022, neither the Company, nor any party on behalf of the Company,
consulted with Marcum regarding either (i) the application of
accounting principles to a specified transaction, either completed
or proposed, or the audit opinion that might be rendered regarding
the Company’s consolidated financial statements, and no written
report or oral advice was provided to the Company that Marcum
concluded was an important factor considered by the Company in
deciding on any accounting, auditing or financial reporting issue,
or (ii) any matter subject to any “disagreement” (as such term is
defined in Item 304(a)(1)(iv) of Regulation S-K and the related
instructions) or a “reportable event” (as such term is defined in
Item 304(a)(1)(v) of Regulation S-K)..
|
Item 5.07. |
Submission of Matters to a Vote of Security
Holders. |
On October 4, 2022, the Company held its 2022 Annual Meeting of
Stockholders (the “Annual Meeting”). At the Annual Meeting, the
Company’s stockholders voted on the six proposals described
below.
As of the record date for the Annual Meeting, there were 94,278,118
shares of common stock outstanding and entitled to vote on each
matter presented for vote at the Annual Meeting. At the Annual
Meeting, 55,018,686 (58.36% of the total outstanding) shares of
common stock were represented in person or by proxy.
The final results for each of the matters submitted to a vote of
stockholders at the Annual Meeting are as follows:
Item 1: The
following five nominees were reelected to serve on the Company’s
Board of Directors until the 2023 Annual Meeting of Stockholders or
until their respective successors have been elected and qualified,
or until their earlier resignation or removal, having received the
following votes:
Name |
|
For |
|
|
Withheld |
|
|
Broker Non-Votes |
|
Scott R. Milford |
|
|
20,330,768 |
|
|
|
12,914,219 |
|
|
|
21,773,699 |
|
Bruce T. Bernstein |
|
|
11,970,368 |
|
|
|
21,274,619 |
|
|
|
21,773,699 |
|
Robert Weinstein |
|
|
12,726,243 |
|
|
|
20,518,744 |
|
|
|
21,773,699 |
|
Donald E. Stout |
|
|
12,998,766 |
|
|
|
20,246,221 |
|
|
|
21,773,699 |
|
Michael Lebowitz |
|
|
20,040,820 |
|
|
|
13,204,167 |
|
|
|
21,773,699 |
|
Item 2: The
appointment of Friedman LLP (now Marcum LLP) as the Company’s
independent registered public accounting firm for the fiscal year
ending December 31, 2022 was ratified, having received the
following votes:
For |
|
|
Against |
|
|
Abstentions |
|
|
Broker Non-Votes |
|
|
40,919,305 |
|
|
|
12,550,696 |
|
|
|
1,548,685 |
|
|
|
— |
|
Item 3: The
amendment to the Company’s Amended and Restated Certificate of
Incorporation to effect a reverse stock split of our issued and
outstanding shares of common stock at a ratio of between 1-for-2
and 1-for-6 was not approved, having received the following
votes:
For |
|
|
Against |
|
|
Abstentions |
|
|
Broker Non-Votes |
|
|
30,539,674 |
|
|
|
24,329,446 |
|
|
|
149,566 |
|
|
|
— |
|
Item 4: The
amendment to the Company’s 2020 Equity Incentive Plan to increase
the number of shares authorized for issuance under the Plan by
7,500,000 shares was approved, having received the following
votes:
For |
|
|
Against |
|
|
Abstentions |
|
|
Broker Non-Votes |
|
|
16,790,763 |
|
|
|
16,018,358 |
|
|
|
453,866 |
|
|
|
21,773,699 |
|
Item 5: The
compensation of the Company’s named executive officers was not
approved, on an advisory basis, by stockholders, having received
the following votes:
For |
|
|
Against |
|
|
Abstentions |
|
|
Broker Non-Votes |
|
|
15,739,057 |
|
|
|
17,149,899 |
|
|
|
356,031 |
|
|
|
21,773,699 |
|
Item 6: The
proposal to approve the adjournment of the Annual Meeting, if
necessary, to solicit additional proxies if there are not
sufficient votes to approve Items 2 through 5 was approved, having
received the following votes:
For |
|
|
Votes Against |
|
|
Abstentions |
|
|
Broker Non-Votes |
|
|
30,248,432 |
|
|
|
24,093,316 |
|
|
|
676,938 |
|
|
|
— |
|
|
Item 9.01. |
Financial Statements and
Exhibits |
|
104 |
Cover Page Interactive Data File
(embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
XpresSpa Group,
Inc. |
|
|
|
Date: October 7, 2022 |
By: |
/s/ Scott R. Milford |
|
Name: |
Scott R.
Milford |
|
Title: |
President and Chief Executive
Officer |
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Sep 2023 to Oct 2023
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Oct 2022 to Oct 2023